 early-initi zidovudin therapi diseas low level persist retroviru mice hybrid mous strain genotyp friend viru complex FV zidovudin zdv time day min initi viral exposur strain mice develop fv-specif neutral antibodi viremia splenic viru titer splenomegali eventu fv-associ death expos mice zdv splenomegali detect viremia last drug treatment day singl anim demonstr viru spleen focal immunoenzym detect viru week splenic viru week none anim hold period placebo-tr mice low level viru latent viru splenocyt cell line propag FV cell time replic viru amplif signific increas number mice posit viru zdv treatment viru exposur effect fv-induc splenomegali death low level persist retroviru mice